Clinical Trial: Efficacy of Tirzepatide in Patients with Type 2 Diabetes and Overweight with Cognitive Impairment Associated with Cerebral Amyloid Angiopathy (CAA): A Controlled, Single-Center, Open-Label, Superiority Trial (China)

China, Aug. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy of Tirzepatide in Patients with Type 2 Diabetes and Overweight with Cognitive Impairment Associated with Cerebral Amyloid Angiopathy (CAA): A Controlled, Single-Center, Open-Label, Superiority Trial'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129902

Registration Time: 2026/08/11

Type: Interventional study

Primary Sponsor: The Third Affiliated Hospital Sun Yat-sen University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=337814

Published by HT Digital Content Services with permission from Health Daily Digest....